newdrugapprovals.org
Mast Ischemia Drug Gets Orphan Drug Designation
Wed, 11/13/2013 Mast Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has designated MST-188 for the treatment of acute limb ischemia as an orphan drug. MST-188 (purifie…